Twitter

Posts Tagged ‘recruiting’


Clinical trial of medication to treat NF2 tumors starting soon

Researchers are recruiting patients for a Phase II clinical trial to test a medication that may slow the progression of Neurofibromatosis Type-2, commonly referred to as NF2.

Read More...

BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia

Condition :   Leukemia, Myeloid, Acute Intervention :   Drug: BI 836858 Sponsors :   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals Recruiting – verified September 2012

Read More...

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

Conditions :   Hepatocellular Carcinoma;   Portal Vein Thrombosis;   Hepatic Portal Vein Tumor Invasion Intervention :   Sponsors :   Hospital Sirio-Libanes;   Hospital Sirio-Libanes Recruiting – verified September 2012

Read More...

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT

Condition :   Multiple Myeloma Intervention :   Other: ACT PET/CT Sponsors :   Chang Gung Memorial Hospital;   Chang Gung Memorial Hospital Recruiting – verified September 2012

Read More...

Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies

Condition :   Cancer Intervention :   Drug: Nerofe Sponsors :   Immune System Key Ltd;   Immune System Key Ltd Not yet recruiting – verified September 2012

Read More...

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Condition :   Peripheral T-cell Lymphoma Intervention :   Drug: SP-02L (darinaparsin for injection) Sponsors :   Solasia Pharma K.K.;   Solasia Pharma K.K.;   Synex Consulting Korea Ltd. Recruiting – verified September 2012

Read More...

A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)

Condition :   Colorectal Cancer Interventions :   Drug: MOVIPREP;   Drug: CitraFleet Sponsors :   Norgine;   Norgine Recruiting – verified September 2012

Read More...

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Conditions :   Psoriasis;   Psoriatic Arthritis Interventions :   Drug: Apremilast 30 mg;   Drug: Etanercept 50 mg;   Drug: Placebo tablet;   Drug: Placebo injection (saline) Sponsors :   Celgene Corporation;   Celgene Corporation Recruiting – verified September 2012

Read More...

MRI for the Early Evaluation of Acute Intracerebral Hemorrhage

Conditions :   Cerebral Hemorrhage;   Intracranial Arteriovenous Malformations;   Intracranial Hemorrhage, Hypertensive;   Brain Neoplasms Intervention :   Device: MRI Scan with the specified sequences below: Sponsors :   Bispebjerg Hospital;   Bispebjerg Hospital Recruiting – verified September 2012

Read More...

Cy/ Dex/ Rapa/ HCQ for Rel/Ref MM

Condition :   Multiple Myeloma Interventions :   Drug: Hydroxychloroquine;   Drug: Rapamycin Sponsors :   OHSU Knight Cancer Institute;   OHSU Knight Cancer Institute Not yet recruiting – verified September 2012

Read More...